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low. Endovascular repair of symptomatic, ruptured and
large PAU is safe and effective with excellent long-term
results. For asymptomatic PAU, serial CT surveillance is
associated with a low rate of rupture or complications.
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Objectives: It is unclear whether the type of proximal
ﬁxation and radial force associated with EVAR have any
long-term impact on the aneurysm neck diameter
(AND). We sought to identify whether AND changes
occur and if any factors are associated with changes in
AND.
Methods: Post-EVAR computed tomography images
were reviewed for all patients undergoing EVAR at two
tertiary medical centers between November 2002 and
March 2012 for whom >6 month post-EVAR imaging
was obtained. The AND was deﬁned as the minor axis 1
cm inferior to the lowest renal artery. AND changes were
calculated as the difference between pre-EVAR AND and
AND at last follow-up scan. EVAR stent-graft type and
other patient characteristics were obtained from chart
review. Multivariable linear regression was used to identify
factors independently associated with long-term AND
changes.
Results: A total of 151 patients meeting inclusion
criteria underwent EVAR with one of ﬁve stent-graft
types. The median age was 70 years old, and median
follow-up time for these patients was 2.05 years. The
mean initial AND was 24.5 mm, and the median AND
change was -0.2 mm/yr. AND expansion >1 mm/yr
occurred in 27 patients (17.8%). Multivariable regression
demonstrated that larger initial AND (P ¼ .001) and dia-
betes mellitus (P ¼ .03) were associated with reduced
risk of AND expansion. The Zenith (P < .001) and
the Talent (P ¼ .07) stent-grafts were associated with
increased risk of AND expansion compared to Excluder,
Aneurx, and Powerlink devices. Overall, stent-grafts with
suprarenal ﬁxation were associated with increased rate of
AND expansion compared to those that did not have
suprarenal ﬁxation (P ¼ .01).
Conclusions: Signiﬁcant AND expansion after
EVAR is uncommon. Necks that do expand only do
so marginally but suprarenal ﬁxation appears to beassociated with an increased risk of long-term AND
expansion. Future studies should address the incidence
of AND during longer follow up and the relationship
between AND expansion and secondary interventions
after EVAR.
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Objectives: There are limited data describing the
“Preclose” technique in TEVAR (P-TEVAR), particularly
in obese patients (BMI $ 30kg/m2), in whom this tech-
nique is thought to be contraindicated. We describe our
experience with P-TEVAR and compare outcomes in
obese and nonobese patients.
Methods: All patients undergoing TEVAR at a single
institution from ’05-11 were reviewed; patients under-
going P-TEVAR were identiﬁed and stratiﬁed by BMI.
Technical success was deﬁned as the ability to achieve
hemostasis and maintain limb perfusion without the need
for surgical repair of the vessel.
Results: Of 536 TEVARs, 359 (67%) P-TEVAR
procedures were completed. For the entire P-TEVAR
cohort, mean age 6 SD was 62.9 6 15.7 yrs with BMI
of 27.56 5.4. Mean sheath diameter, largest TEVAR stent
diameter, and number of Perclose deployments were 22.4
6 2.5F, 34.6 6 7.8 mm and 2.1 6 0.4, respectively. Mean
access vessel inner diameter was 8.0 6 2.0 mm with
average depth of 35.6 6 17.5 mm. Adjunctive iliac stents
were used in 9.4% (n ¼ 34). Overall “Preclose” success
rate was 92.6%:92.2% for nonobese patients and 93.8%
for obese patients (P ¼ .57). 3 patients required subse-
quent operations for access complications: two obese
patients (2%) and one nonobese patient (0.3%). By univar-
iate analysis, higher age, increased sheath size, larger aortic
stent diameter, use of more than 2 Perclose devices, need
for iliac stents, and higher femoral artery calcium score
were associated with failure. Independent predictors of
failure were adjunctive iliac stent (OR, 8.9; 95% CI, 2.9-
27.4; P ¼ .003), >2 Perclose devices (OR, 6.7; 95% CI,
2.2-20.2; P ¼ .001), and decreased access vessel diameter
(OR, 1.5; 95% CI, 1.1-2; P ¼ .008).
Conclusions: Percutaneous endovascular repair of
thoracic aortic pathology is safe. Obesity does not appear
to be a contraindication for the “Preclose” technique.
Patients predicted to need adjunctive stenting or possessing
smaller access vessel diameters with greater degree of calci-
ﬁcation are at highest risk of failure and selective use of this
technique is recommended.
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Objectives: Open repair (OR) of inﬂammatory
abdominal aortic aneurysms (IAAA) is challenging due to
adhesions of the aneurysm with the surrounding structures
and can be associated with signiﬁcant morbidity. In recent
years endovascular aneurysm repair (EVAR) has emerged
as a promising, less invasive approach, although there is
a paucity of studies comparing directly these two methods
of repair. The aim of our retrospective comparative investi-
gation was to study IAAA outcome after OR compared to
EVAR.
Methods: Twenty seven patients (26 males, median
age 67 years) with a nonruptured IAAA were included.
Mean (sd) IAAA size was 6.0 (1.3) cm. Preoperative
pain was reported in 15 cases (56%). Nine patients
were managed with EVAR under local (n ¼ 8) or spinal
anaesthesia (n ¼ 1) and 18 with OR under general
anaesthesia.
Results: Preoperative characteristics of the two
study groups were comparable. In the EVAR group,
transfusion needs were reduced by 67%, procedure dura-
tion was shortened by 58% and postoperative hospitali-
zation was shortened by 4 days (50%), all statistically
signiﬁcant compared to OR (Table). A trend for
reduced morbidity and in-hospital mortality after EVAR
was also observed. No AAA-related death occurred
during follow-up.
Conclusions: Endovascular repair of IAAAs, accom-
plished in a less invasive manner, is associated with
a smoother postoperative course and shorter hospital stay
compared to OR. Further studies should focus on the
role of EVAR and provide long-term results, including
total and aneurysm-related mortality.Table. Results of endovascular and open repair of
inﬂammatory abdominal aortic aneurysms
Endovascular Open repair
repair (n ¼ 9) (n ¼ 16) P valueNumber of transfused
RBC units [median
(interquartile range)]1.0 (0-1) 3.0 (2.0-5.0) .001Procedure duration [median
(interquartile range)] (minutes)70 (68-105) 240 (180-360) .001Postoperative hospitalization
[median (interquartile
range)] (days)4.0 (2.5-7) 8.0 (6.5-11.5) .004Morbidity 11% 33% .36aIn-hospital mortality 0% 11% .54
Overall 5-year survival 100% 75% .75aOdds ratio 4.0.
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Mid-Term Results and Morphological Neck Changes
After EVAR in Patients With Severe Proximal Neck
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Objectives: We investigate the inﬂuence of severe
proximal neck angulation on mid-term outcome using
the Endurant Stentgraft.
Methods: A joint database of 3 tertiary institutions
was inquired. Inclusion in the study group was: suprarenal
neck angle (a) >60 or infrarenal neck angle (b) >75 (if
neck length #10 mm, a > 45 or b > 60). These were
compared to a matched control group without signiﬁcant
angulation, treated in the same period with the same
device. Primary endpoint was clinical success. 3D recon-
struction was used for measurements. Neck changes over
follow-up (FU) were evaluated. Estimates for clinical
success were obtained from Kaplan-Meier plots.
Results: From 2008 to 2009, 232 patients were
treated, and 45 were included in the study group (age 74
6 8, 86% men). Mean a was 51 6 21 and b was 81 6
16. Median FU was 3.0 yrs (2.0-3.4). Compared to the
control group (N ¼ 65), no differences were found in clin-
ical success (P ¼ .79, Fig). Two post-EVAR ruptures
occurred, one in each group. No differences were found in
rate or type of reinterventions. Over FU, neck dilatation
>2 mm occurred in 45% vs 43% in controls (P ¼ .23),
